Recovery of functional enzyme from amyloid fibrils

FEBS Letters

Volumn 584, Issue 6, 2010, Pages 1139-1142

  Agócs, Gergely ^a   Solymosi, Katalin ^b   Varga, Andrea ^c   Módos, Károly ^a   Kellermayer, Miklós ^a   Závodszky, Péter ^c   Fidy, Judit ^a   Osváth, Szabolcs ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c INSTITUTE OF ENZYMOLOGY   (Hungary)

Author keywords

Amyloid; Enzyme activity; Protein aggregation; Refolding

Indexed keywords

AMYLOID; PHOSPHOGLYCERATE KINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STABILITY; MOLECULAR MECHANICS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROCESSING;

AMYLOID; ENZYME STABILITY; HYDROGEN-ION CONCENTRATION; LABORATORY TECHNIQUES AND PROCEDURES; OSMOLAR CONCENTRATION; PHOSPHOGLYCERATE KINASE; PROTEIN DENATURATION; PROTEIN FOLDING; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TEMPERATURE;

EID: 77950369417     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.01.058     Document Type: Article

References (30)

1. Kramer M.L., Kratzin H.D., Schmidt B., Römer A., Windl O., Liemann S., Hornemann S., Kretzschmar H. Prion protein binds copper within the physiological concentration range. J. Biol. Chem. 2001, 276:16711-16719.
2. Jahn T.R., Radford S.E. Folding versus aggregation: polypeptide conformations on competing pathways. Arch. Biochem. Biophys. 2008, 469:100-117.
3. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10(Suppl.):S10-S17.
4. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
5. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24:329-332.
6. Guijarro J.I., Sunde M., Jones J.A., Campbell I.D., Dobson C.M. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. USA 1998, 95:4224-4228.
7. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. USA 1999, 96:3590-3594.
8. Damaschun G., Damaschun H., Gast K., Zirwer D. Proteins can adopt totally different folded conformations. J. Mol. Biol. 1999, 291:715-725.
9. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., Apostol M.I., Thompson M.J., Balbirnie M., Wiltzius J.J.W., McFarlane H.T., Madsen A.Ø., Riekel C., Eisenberg D. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007, 447:453-457.
10. Nelson R., Sawaya M.R., Balbirnie M., Madsen A.Ø., Riekel C., Grothe R., Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005, 435:773-778.
11. Osváth S., Jäckel M., Agócs G., Závodszky P., Köhler G., Fidy J. Domain interactions direct misfolding and amyloid formation of yeast phosphoglycerate kinase. Proteins 2006, 62:909-917.
12. Dobson C.M. Protein folding and misfolding. Nature 2003, 426:884-890.
13. Wang L., Maji S.K., Sawaya M.R., Eisenberg D., Riek R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol. 2008, 6:e195.
14. Fowler D.M., Koulov A.V., Alory-Jost C., Marks M.S., Balch W.E., Kelly J.W. Functional amyloid formation within mammalian tissue. PLoS Biol. 2006, 4:e6.
15. Booth D.R., Sunde M., Bellotti V., Robinson C.V., Hutchinson W.L., Fraser P.E., Hawkins P.N., Dobson C.M., Radford S.E., Blake C.C., Pepys M.B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997, 385:787-793.
16. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416:507-511.
17. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
18. Foguel D., Suarez M.C., Ferrão-Gonzales A.D., Porto T.C.R., Palmieri L., Einsiedler C.M., Andrade L.R., Lashuel H.A., Lansbury P.T., Kelly J.W., Silva J.L. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities. Proc. Natl. Acad. Sci. USA 2003, 100:9831-9836.
19. Dirix C., Meersman F., MacPhee C.E., Dobson C.M., Heremans K. High hydrostatic pressure dissociates early aggregates of TTR105-115, but not the mature amyloid fibrils. J. Mol. Biol. 2005, 347:903-909.
20. Osváth S., Gruebele M. Proline can have opposite effects on fast and slow protein folding phases. Biophys. J. 2003, 85:1215-1222.
21. Cserpán I., Vas M. Effects of substrates on the heat stability and on the reactivities of thiol groups of 3-phosphoglycerate kinase. Eur. J. Biochem. 1983, 131:157-162.
22. Tompa P., Hong P.T., Vas M. The phosphate group of 3-phosphoglycerate accounts for conformational changes occurring on binding to 3-phosphoglycerate kinase. Enzyme inhibition and thiol reactivity studies. Eur. J. Biochem. 1986, 154:643-649.
23. Varga A., Flachner B., Gráczer E., Osváth S., Szilágyi A.N., Vas M. Correlation between conformational stability of the ternary enzyme-substrate complex and domain closure of 3-phosphoglycerate kinase. FEBS J. 2005, 272:1867-1885.
24. Damaschun G., Damaschun H., Fabian H., Gast K., Kröber R., Wieske M., Zirwer D. Conversion of yeast phosphoglycerate kinase into amyloid-like structure. Proteins 2000, 39:204-211.
25. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993, 2:404-410.
26. Galántai R., Bárdos-Nagy I., Módos K., Kardos J., Závodszky P., Fidy J. Serum albumin-lipid membrane interaction influencing the uptake of porphyrins. Arch. Biochem. Biophys. 2004, 373:261-270.
27. Khurana R., Uversky V.N., Nielsen L., Fink A.L. Is Congo red an amyloid-specific dye?. J. Biol. Chem. 2001, 276:22715-22721.
28. Szilágyi A.N., Vas M. Sequential domain refolding of pig muscle 3-phosphoglycerate kinase: kinetic analysis of reactivation. Fold. Des. 1998, 3:565-575.
29. Modler A.J., Gast K., Lutsch G., Damaschun G. Assembly of amyloid protofibrils via critical oligomers-a novel pathway of amyloid formation. J. Mol. Biol. 2003, 325:135-148.
30. Uversky V.N., Fink A.L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 2004, 1698:131-153.